News

By I. Edwards HealthDay ReporterMONDAY, March 24, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has approved a new drug for a serious heart condition that affects thousands of people.The drug, called Amvuttra (vutrisiran), is made by Alnylam Pharmaceuticals and is used to treat transthyretin amyloid cardiomyopathy …

By I. Edwards HealthDay ReporterMONDAY, March 24, 2025 (HealthDay News) — A fake web page designed to look like the U.S. Centers for Disease Control and Prevention’s (CDC) vaccine safety site has been taken down on orders from health secretary Robert F. Kennedy Jr.The site was linked to Children’s Health …

Tremfya is the first and only interleukin-23 inhibitor offering both subcutaneous and intravenous induction options for Crohn disease

Model that incorporated age at diagnosis for each chronic condition developed at 60 years or younger was best performing for premature death

Findings persist across various periods

Higher weighted years with overweight/obesity linked to increased risk for overall, aggressive, fatal, and clear-cell renal cell carcinoma

Prevalence and severity of refractive astigmatism and corneal astigmatism increased among schoolchildren

Microplastic particles ranged in size from 1 to 62 µm, with about 90 percent ranging from 1 to 20 µm

Fine details better visualized in denoised ultra-low-dose CT images in adults who were immunocompromised

Findings seen during 18+ years of follow-up and persist when accounting for sociodemographic factors